Lawrence A. Kenyon
CHIEF FINANCIAL OFFICER at Outlook Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: Outlook Therapeutics Inc., 2 years.
Outlook Therapeutics Inc.
Director · Chief Financial Officer
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 14, 2026 | Outlook Therapeutics Inc. | Open-market purchase | +101,010 | — | — |
| Sep 26, 2024 | Outlook Therapeutics Inc. | Open-market purchase | +5,000 | $5.69 | $28,450 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.